| (210) | Number of the EPO application | 22182756 |
| (220) | Filing date of the EPO application | 2019.03.25 |
| (80) | EPO patent specification publication (B) | EPB nr. 36/2025, 2025.09.03 |
| (110) | EPO patent number | 4088720 |
| (21) | Number of the application | e 2022 1282 |
| (71) | Name(s) of applicant(s), code of the country | Pfizer Ireland Pharmaceuticals Unlimited Company, IE; |
| (72) | Name(s) of inventor(s), code of the country | CORIC Vladimir, US;
CROOP Robert, US; |
| (73) | Name(s) of owner(s), code of the country | Pfizer Ireland Pharmaceuticals Unlimited Company, IE; |
| (54) | Title of the invention | RIMEGEPANT FOR CGRP RELATED DISORDERS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/4545 (2006.01.01); A61P 25/06 (2006.01.01); A61K 9/00 (2006.01.01); A61K 9/20 (2006.01.01); A61K 9/19 (2006.01.01); C07D 471/04 (2006.01.01) |
| (52) | Cooperative Patent Classification | A61K 9/2018 (EP); A61K 9/2054 (EP); A61K 9/2063 (EP); A61K 31/4545 (EP); A61P 25/06 (EP); C07D 471/04 (EP) |
| (19) | Country | IE |
| (41) | Date of publication of the application | 2022.12.31 |
| (30) | Priority | 201862647794 P, 2018.03.25, US; 201862664761 P, 2018.04.30, US; 201862774285 P, 2018.12.02, US; 201862777180 P, 2018.12.09, US; 201862777625 P, 2018.12.10, US |